ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

12,038Medicare Part D Prescriptions Filled, Including Refills
$741K Total Retail Price of All Prescriptions
360 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 522 432
AMLODIPINE BESYLATE 451 381
OMEPRAZOLE 420 295
PRAVASTATIN SODIUM 347 297
METOPROLOL SUCCINATE 332 294
METOPROLOL TARTRATE 270 245
ATORVASTATIN CALCIUM 269 226
HYDROCODONE-ACETAMINOPHEN 269 155 S3
METFORMIN HCL ER 269 226
CRESTOR 245 185
WARFARIN SODIUM 230 159
ISOSORBIDE MONONITRATE ER 220 193
SIMVASTATIN 217 171
LISINOPRIL 172 161
HYDROCHLOROTHIAZIDE 166 164
CITALOPRAM HBR 152 133
POTASSIUM CHLORIDE 146 134
ZOLPIDEM TARTRATE 140 95
METFORMIN HCL 134 96
TAMSULOSIN HCL 133 133
PANTOPRAZOLE SODIUM 129 104
DIOVAN 128 116
ZETIA 125 125
AMLODIPINE BESYLATE-BENAZEPRIL 121 104
AZITHROMYCIN 116 87
NEXIUM 112 85
BENICAR 110 87
TRAMADOL HCL 110 94
SYNTHROID 108 84
RAMIPRIL 104 95
CLOPIDOGREL 102 85
TORSEMIDE 101 75
FUROSEMIDE 100 88
ATENOLOL 97 86
LIPITOR 91 89
DIGOXIN 87 76
BENAZEPRIL HCL 85 57
PLAVIX 78 68
SPIRIVA 74 53
AMOXICILLIN 73 51
NIASPAN 71 47
JANUVIA 71 55
DIOVAN HCT 70 63
INSULIN SYRINGE 68 63
DONEPEZIL HCL 68 63
LOSARTAN POTASSIUM 65 54
XARELTO 65 65
WELCHOL 63 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 57
LOVAZA 61 48
ADVAIR DISKUS 60 36
GABAPENTIN 59 21
ESCITALOPRAM OXALATE 59 47
PRADAXA 57 57
VENLAFAXINE HCL ER 56 43
FLUTICASONE PROPIONATE 55 45
SERTRALINE HCL 52 28
GLIPIZIDE ER 51 51
GLIPIZIDE XL 51 36
CLONIDINE HCL 50 43
RANITIDINE HCL 50 49
SINGULAIR 50 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.